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Alzheimer's dementia (AD) is a degenerative brain disorder characterized mainly by cholinergic failure, but other
neuro-transmitters are also deﬁcient especially at late stages of the disease. Misfolded β-amyloid peptide has
been identiﬁed as a causative agent, however inﬂammatory changes also play a pivotal role. Even though the
most prominent pathology is seen in the cognitive functions, speciﬁc abnormalities of the central nervous system
(CNS) are also reﬂected in the periphery, particularly in the immune responses of the body. The aim of this study
was to characterize the dopaminergic and serotonergic systems in AD, which are also markedly disrupted along
with the hallmark acetyl-choline dysfunction. Peripheral blood mono-nuclear cells (PBMCs) from demented pa-
tients were judged against comparison groups including individuals with late-onset depression (LOD), as well as
non-demented and non-depressed subjects. Cellular sub-populations were evaluated by mono-clonal antibodies
against various cell surface receptors: CD4/CD8 (T-lymphocytes), CD19 (B-lymphocytes), CD14 (monocytes), and
CD56 (natural-killer (NK)-cells). The expressions of dopamine D3 and D4, as well as serotonin 5-HT1A, 5-HT2A,
5-HT2B and 5-HT2C were also assessed. There were no signiﬁcant differences among the study groups with re-
spect to the frequencyof the cellular sub-types, however a uniqueprofound increase in 5-HT2C receptor exclusively
in NK-cells was observed in AD. The disease-speciﬁc expression of 5-HT2C, as well as the NK-cell cyto-toxicity, has
been linked with cognitive derangement in dementia. These changes not only corroborate the existence of bi-
directional communication between the immune system and the CNS, but also elucidate the role of inﬂammatory
activity in AD pathology, and may serve as potential biomarkers for less invasive and early diagnostic purposes as
well.
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